Patent · US Active

Genome engineering

US10563225B2 · kind B2 · utility

6Cited by
2References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2014
Grant dateFeb 18, 2020
Priority date
Expiry dateJun 30, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/003
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods are provided for the use of Cas9 in genome engineering of stem cells. Methods include introducing into the stem cell a first foreign nucleic acid encoding a guide RNA complementary to a target DNA and which guides a Cas9 enzyme to the target DNA, wherein the RNA and the enzyme are members of a co-localization complex for the target DNA, introducing into the stem cell a second foreign nucleic acid encoding a donor nucleic acid sequence, wherein the guide RNA and the donor nucleic acid sequences are expressed, wherein the guide RNA and the Cas 9 enzyme co-localize to the target DNA, the Cas 9 enzyme cleaves the target DNA and the donor nucleic acid is inserted into the target DNA to produce altered DNA in the stem cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.